Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks
Abstract
Polyendocrine metabolic ovarian syndrome [PMOS; previously known as polycystic ovary syndrome (PCOS)] is an endocrine condition affecting 10%-13% of women of reproductive age, with cardiometabolic, reproductive and psychological features. The PMOS guidelines have established recommendations for its management, which can include pharmacological, lifestyle and/or traditional medicines. The aim of this narrative review is to explore the pathophysiology, treatment recommendations and current evidence for lifestyle management for those with PMOS. Using the consolidated framework for implementation research (CFIR) and capability, opportunity, motivation and behaviour (COM-B) frameworks, this review identifies barriers and facilitators to implement lifestyle recommendations for PMOS, followed by strategies to support improvement in lifestyle management. There is limited high-quality evidence to support specific physical activity and dietary recommendations for those with PMOS. Underlying physiological mechanisms driving PMOS can impact energy expenditure, metabolism, appetite and satiety hormones, acting as barriers for weight and lifestyle-management strategies. Qualitative research suggests that implementation of lifestyle-management strategies from the PMOS guidelines has not been adopted. From a psychosocial perspective, those with PMOS often report that their health needs are not being met by health professionals. This might be related to a disproportionate focus on…
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.